The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
A bit harsh Noodleman!
The put option negotiated with CDT was a good bit of work...considering the original investment in the COVID 19 aspect of AZ 1656 was all but dead in the water. And getting double the amount of shares compared to the original CDT listing price with no restrictions was also good work . As was the timing of the exercise when CDT was on the rise.
The fact that the Vela price has yet to catch up is an opportunity if a bit frustrating.
CSFS is also still flying at year highs
Double already!
back of a *** packet maths :
for every $1.25 rise of cdt over $ 3.5 ( break even on original investment ) should be 0.01p on vela.
if current investments + poor sentiment pre exercise gave us 0.175p…we should now be 0.0375p on similar poor sentiment after exercising the option ….0.05p on market cap with neutral sentiment. and 0.06p plus on market cap and more positive sentiment .
good time to buy
It all helps! VELA's option is up 20% as they exercised at $5. Ciz had no option but to exercise at $10. They were at one point 90% down but now only 40% down...assuming they still have them.
But its not all about that here with such exciting prospects lining up. I am continually topping up here with any profits from VELA or elsewhere
The £6,819,000 value as far as I can see is with the put option valued at £4 million . The exercised option is currently worth about a million more in CDT shares .
Given some investments (ENS) have decreased and others increased (CSFS) since 30 Sept then a conservative ‘Live’ valuation would be around £7.5million= 0.045p+
“ Ltd- the board are taking their time with exercising the option. Although i agree, once they do it will fly”
They did on the 1st Dec Suthy! Keep up!
I’ll be putting profits back in here at these levels